F.Y.I.

The Daily Aus launches podcast series ‘Investigating Ozempic’

A new podcast from The Daily Aus explores young Australians’ relationship with weight-loss medications like Ozempic and Wegovy.

The announcement:

The Daily Aus (TDA) has announced the launch of Investigating Ozempic — an original podcast series examining the complex world of medicated weight loss.

Hosted and produced by TDA’s features editor Emma Gillespie, Investigating Ozempic dives deep into Australia’s medical weight-loss industry, offering unprecedented insight into how young people are engaging with high-profile medications like Ozempic, Wegovy and Mounjaro. Over three episodes, the podcast explores the complex medical, ethical, and commercial landscape behind the global rise of these drugs.

With in-depth interviews, firsthand accounts, and commentary from health professionals, the series raises questions about patient care, safety protocols, and marketing and prescribing practices in a rapidly evolving health sector.

A survey of more than 23,000 TDA followers found 11% of young people have used Ozempic or a similar drug, while 43% of respondents said they want to (or have previously wanted to) try weight-loss medication.

“Ozempic has dominated headlines over recent years, but the experience of young Australians has been missing from the conversation,” Investigating Ozempic host Emma Gillespie said.

“We received overwhelming feedback from our audience, including hundreds of lived-experience anecdotes, warranting further scrutiny into how these medications are being prescribed, monitored and marketed to young people. This series aims to provide clarity and context to an issue that touches many aspects of young people’s lives.”

The first two episodes of Investigating Ozempic is available now on Spotify or wherever you get your podcasts, with part three dropping on 20 and 21 May, respectively.

Source: ARN

ADVERTISEMENT

Get the latest media and marketing industry news (and views) direct to your inbox.

Sign up to the free Mumbrella newsletter now.

"*" indicates required fields

 

SUBSCRIBE

Sign up to our free daily update to get the latest in media and marketing.